Altimmune ALT
NASDAQ ALT
$3.42 +0.19 (+5.90%)
As of: Sep 4, 2026 · 3:59 PM EDT

Altimmune (ALT) Short-Term Debt issuances (2012 - 2014)

Altimmune (ALT) posted quarterly Short-Term Debt issuances of -$1.1 million for Q1 2014, down 85593.88% year-over-year from N/an in Q1 2013, and down 200.0% quarter-over-quarter from $1.1 million in Q4 2013.

Analysis

Altimmune (ALT) Short-Term Debt issuances (2012 - 2014) Analysis & Trends

Altimmune (ALT) has reported Short-Term Debt issuances for 3 consecutive years, with -$1.1 million the latest figure, recorded in Q1 2014.

  • In Q1 2014, Short-Term Debt issuances fell 85593.88% year-over-year to -$1.1 million; the TTM figure through Dec 2014 stood at -$1.1 million (down 357.24% YoY), while the FY2014 annual figure was -$1.1 million, down 357.24% from the prior year.
  • Short-Term Debt issuances fell to -$1.1 million in Q1 2014 per ALT's latest filing, from $1.1 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $1.1 million in Q4 2013 and bottomed at -$1.2 million in Q3 2013.
  • Historically, Short-Term Debt issuances has averaged -$50080.3 across 3 years, with a median of -$1274.0 in 2013.
  • Annual changes were most pronounced in 2013 — Short-Term Debt issuances soared 793.87% — and 2014, when it sank 85593.88%.
  • Altimmune's Short-Term Debt issuances stood at $122137.0 in 2012, then jumped by 793.87% to $1.1 million in 2013, then slumped by 200.0% to -$1.1 million in 2014.
  • Business Quant data shows ALT's Short-Term Debt issuances at -$1.1 million in Q1 2014, $1.1 million in Q4 2013, and -$1.2 million in Q3 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Altimmune 636.07 Mn 636.07 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 -1.09 Mn
Dec 31, 2013 1.09 Mn
Sep 30, 2013 -1.17 Mn
Jun 30, 2013 -161,090.00
Mar 31, 2013 -1,274.00
Dec 31, 2012 122,137.00
Mar 31, 2012 857,808.00